Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Panel Rejects First Artificial Heart - Medical Product Outsourcing

What are you searching for?

Sign in

FDA Panel Rejects First Artificial Heart

By: Jason Lawton

NULL

Bram Zuckerman, the FDA’s division director of cardiovascular devices, said the agency and Abiomed would carefully go through the meeting’s transcript and “develop a plan to move forward,” according to the Wall Street Journal.

Panel members were concerned that most of the 14 patients who received the device suffered from bleeding complications, and that half the patients died of a stroke. They were put on blood-thinning medication, but regulating the medication became difficult.

“I think the bleeding and the strokes are a deal-breaker for me,” said Christopher J. White, a panel member and cardiologist at the Ochsner Clinic in New Orleans.

The device was implanted in 14 men with severe heart failure who had less than 30 days to live. All have since died after living for an average of 5.2 months following implant.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Add Medical Product Outsourcing as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics